Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
Australian School of Petroleum
Business School
Elder Conservatorium of Music
Law School
School of Agriculture, Food and Wine
School of Animal and Veterinary Sciences
School of Architecture and Built Environment
School of Chemical Engineering
School of Chemistry and Physics
School of Civil, Environmental and Mining Engineering
School of Computer Science
School of Dentistry
School of Earth and Environmental Sciences
School of Economics
School of Education
School of Electrical and Electronic Engineering
School of History and Politics
School of Humanities
School of Mathematical Sciences
School of Mechanical Engineering
School of Medical Sciences
School of Medicine
School of Molecular and Biomedical Science
School of Nursing
School of Paediatrics & Reproductive Health
School of Population Health & Clinical Practice
School of Psychology
School of Social Sciences
School of Translational Health Science
Research Outputs
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 21-30 of 30 (Search time: 0.004 seconds).
previous
1
2
3
next
Item hits:
Preview
Issue Date
Title
Author(s)
2011
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after Imatinib resistance is predictive of outcome during subsequent therapy
Parker, W.
;
Lawrence, R.
;
Ho, M.
;
Irwin, D.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2004
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
Branford, S.
;
Rudzki, Z.
;
Parkinson, I.
;
Grigg, A.
;
Taylor, K.
;
Seymour, J.
;
Durrant, S.
;
Browett, P.
;
Schwarer, A.
;
Arthur, C.
;
Catalano, J.
;
Leahy, M.
;
Filshie, R.
;
Bradstock, K.
;
Herrmann, R.
;
Joske, D.
;
Lynch, K.
;
Hughes, T.
2011
Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells
Tang, M.
;
Gonen, M.
;
Quintas-Cardama, A.
;
Cortes, J.
;
Kantarjian, H.
;
Field, C.
;
Hughes, T.
;
Branford, S.
;
Michor, F.
2012
Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile
Parker, W.
;
Ho, M.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2012
Initial molecular response at 3 months may predict both response and event-free survival at 24 months in Imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with Nilotinib
Branford, S.
;
Kim, D.
;
Soverini, S.
;
Haque, A.
;
Shou, Y.
;
Woodman, R.
;
Kantarjian, H.
;
Martinelli, G.
;
Radich, J.
;
Saglio, G.
;
Hochhaus, A.
;
Hughes, T.
;
Muller, M.
2003
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Branford, S.
;
Rudzki, Z.
;
Walsh, S.
;
Parkinson, I.
;
Grigg, A.
;
Szer, J.
;
Taylor, K.
;
Hermann, R.
;
Seymour, J.
;
Arthur, C.
;
Joske, D.
;
Lynch, K.
;
Hughes, T.
2010
Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study
Cortes, A.
;
Baccarani, M.
;
Guilhot, F.
;
Druker, B.
;
Branford, S.
;
Kim, D.
;
Pane, F.
;
Pasquini, R.
;
Goldberg, S.
;
Kalaycio, M.
;
Moiraghi, B.
;
Rowe, J.
;
Tothova, E.
;
de Souza, C.
;
Rudoltz, M.
;
Yu, R.
;
Krahnke, T.
;
Kantarjian, H.
;
Radich, J.
;
Hughes, T.
2011
BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib teatment
Stein, A.
;
Bottino, D.
;
Modur, V.
;
Branford, S.
;
Kaeda, J.
;
Goldman, J.
;
Hughes, T.
;
Radich, J.
;
Hochhaus, A.
2011
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
Esposito, N.
;
Colavita, I.
;
Quintarelli, C.
;
Sica, A.
;
Peluso, A.
;
Luciano, L.
;
Picardi, M.
;
Vecchio, L.
;
Buonomo, T.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Russo, D.
;
Branford, S.
;
Saglio, G.
;
Vaz de Melo, J.
;
Martinelli, R.
;
Ruoppolo, M.
;
Kalebic, T.
;
Martinelli, G.
;
et al.
2008
Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: Implications for defining sensitivity in minimal residual disease
Ross, D.
;
Watkins, D.
;
Hughes, T.
;
Branford, S.
Discover
Author
8
Radich, J.
6
Grigg, A.
6
Hochhaus, A.
6
Ross, D.
6
Rudzki, Z.
5
Seymour, J.
5
White, D.
4
Arthur, C.
4
Kim, D.
4
Muller, M.
.
next >
Subject
27
Leukemia, Myelogenous, Chronic, B...
23
Fusion Proteins, bcr-abl
23
Pyrimidines
22
Benzamides
22
Imatinib Mesylate
22
Piperazines
14
Antineoplastic Agents
12
Treatment Outcome
11
Adult
11
Drug Resistance, Neoplasm
.
next >
Date issued
1
2020 - 2022
14
2010 - 2019
15
2000 - 2009